The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Cell-Free DNA (cfDNA) Testing Market Research Report 2025

Global Cell-Free DNA (cfDNA) Testing Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1924581

No of Pages : 81

Ask Your Query

Synopsis

Cell-Free DNA are fragments of DNA which circulate in the blood fluid and can be utilized as valuable biomarkers. It is a new technology in which small quantity of liquid sample (saliva, urine, or blood) from the patient is collected to examine the freely flowing DNA. Cell-Free DNA (cfDNA) is a noninvasive screening test used to help detect graft rejection, identify mutations in cancer patients and detect various chromosomal abnormalities in the fetus, to know the gender of the fetus. The discovery of cfDNA has opened up to new potentials in the field of oncology, gynecology, transplantation and infectious diseases.

The global Cell-Free DNA (cfDNA) Testing market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

Increased incidences of diseases like chromosomal abnormalities due to increasing maternal age, changing lifestyle, unhealthy diet habits and rising prevalence of cancer, also in addition to it increasing healthcare expenditure, and rising healthcare awareness are the reasons driving the cell-free DNA market.

This report aims to provide a comprehensive presentation of the global market for Cell-Free DNA (cfDNA) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cell-Free DNA (cfDNA) Testing.

Report Scope

The Cell-Free DNA (cfDNA) Testing market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cell-Free DNA (cfDNA) Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Cell-Free DNA (cfDNA) Testing companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Agilent Technology
  • Allenex
  • Biocept
  • Biodesix
  • CareDx
  • Guardant Health
  • Illumania
  • Invited
  • Natera
  • Quest Diagnostics
  • Roche Holdings
  • Sequenom
  • Trovagene

Segment by Type

  • Donor-Derived Cell-Free DNA (DdcfDNA)
  • Circulating Cell-Free Tumor DNA (CtDNA)
  • Cell-Free Fetal DNA (NIPT)

Segment by Application

  • Hospital
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cell-Free DNA (cfDNA) Testing companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Donor-Derived Cell-Free DNA (DdcfDNA)
1.2.3 Circulating Cell-Free Tumor DNA (CtDNA)
1.2.4 Cell-Free Fetal DNA (NIPT)
1.3 Market by Application
1.3.1 Global Cell-Free DNA (cfDNA) Testing Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Ambulatory Surgical Centers
1.3.4 Cancer Research Institutes
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cell-Free DNA (cfDNA) Testing Market Perspective (2019-2030)
2.2 Cell-Free DNA (cfDNA) Testing Growth Trends by Region
2.2.1 Global Cell-Free DNA (cfDNA) Testing Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Cell-Free DNA (cfDNA) Testing Historic Market Size by Region (2019-2024)
2.2.3 Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Region (2025-2030)
2.3 Cell-Free DNA (cfDNA) Testing Market Dynamics
2.3.1 Cell-Free DNA (cfDNA) Testing Industry Trends
2.3.2 Cell-Free DNA (cfDNA) Testing Market Drivers
2.3.3 Cell-Free DNA (cfDNA) Testing Market Challenges
2.3.4 Cell-Free DNA (cfDNA) Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue
3.1.1 Global Top Cell-Free DNA (cfDNA) Testing Players by Revenue (2019-2024)
3.1.2 Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Players (2019-2024)
3.2 Global Cell-Free DNA (cfDNA) Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Cell-Free DNA (cfDNA) Testing Revenue
3.4 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio
3.4.1 Global Cell-Free DNA (cfDNA) Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell-Free DNA (cfDNA) Testing Revenue in 2023
3.5 Cell-Free DNA (cfDNA) Testing Key Players Head office and Area Served
3.6 Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
3.7 Date of Enter into Cell-Free DNA (cfDNA) Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Cell-Free DNA (cfDNA) Testing Breakdown Data by Type
4.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Type (2019-2024)
4.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2025-2030)
5 Cell-Free DNA (cfDNA) Testing Breakdown Data by Application
5.1 Global Cell-Free DNA (cfDNA) Testing Historic Market Size by Application (2019-2024)
5.2 Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Cell-Free DNA (cfDNA) Testing Market Size (2019-2030)
6.2 North America Cell-Free DNA (cfDNA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2019-2024)
6.4 North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell-Free DNA (cfDNA) Testing Market Size (2019-2030)
7.2 Europe Cell-Free DNA (cfDNA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2019-2024)
7.4 Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size (2019-2030)
8.2 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2019-2024)
8.4 Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cell-Free DNA (cfDNA) Testing Market Size (2019-2030)
9.2 Latin America Cell-Free DNA (cfDNA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2019-2024)
9.4 Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size (2019-2030)
10.2 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2019-2024)
10.4 Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Agilent Technology
11.1.1 Agilent Technology Company Detail
11.1.2 Agilent Technology Business Overview
11.1.3 Agilent Technology Cell-Free DNA (cfDNA) Testing Introduction
11.1.4 Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.1.5 Agilent Technology Recent Development
11.2 Allenex
11.2.1 Allenex Company Detail
11.2.2 Allenex Business Overview
11.2.3 Allenex Cell-Free DNA (cfDNA) Testing Introduction
11.2.4 Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.2.5 Allenex Recent Development
11.3 Biocept
11.3.1 Biocept Company Detail
11.3.2 Biocept Business Overview
11.3.3 Biocept Cell-Free DNA (cfDNA) Testing Introduction
11.3.4 Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.3.5 Biocept Recent Development
11.4 Biodesix
11.4.1 Biodesix Company Detail
11.4.2 Biodesix Business Overview
11.4.3 Biodesix Cell-Free DNA (cfDNA) Testing Introduction
11.4.4 Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.4.5 Biodesix Recent Development
11.5 CareDx
11.5.1 CareDx Company Detail
11.5.2 CareDx Business Overview
11.5.3 CareDx Cell-Free DNA (cfDNA) Testing Introduction
11.5.4 CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.5.5 CareDx Recent Development
11.6 Guardant Health
11.6.1 Guardant Health Company Detail
11.6.2 Guardant Health Business Overview
11.6.3 Guardant Health Cell-Free DNA (cfDNA) Testing Introduction
11.6.4 Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.6.5 Guardant Health Recent Development
11.7 Illumania
11.7.1 Illumania Company Detail
11.7.2 Illumania Business Overview
11.7.3 Illumania Cell-Free DNA (cfDNA) Testing Introduction
11.7.4 Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.7.5 Illumania Recent Development
11.8 Invited
11.8.1 Invited Company Detail
11.8.2 Invited Business Overview
11.8.3 Invited Cell-Free DNA (cfDNA) Testing Introduction
11.8.4 Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.8.5 Invited Recent Development
11.9 Natera
11.9.1 Natera Company Detail
11.9.2 Natera Business Overview
11.9.3 Natera Cell-Free DNA (cfDNA) Testing Introduction
11.9.4 Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.9.5 Natera Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Detail
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Cell-Free DNA (cfDNA) Testing Introduction
11.10.4 Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.10.5 Quest Diagnostics Recent Development
11.11 Roche Holdings
11.11.1 Roche Holdings Company Detail
11.11.2 Roche Holdings Business Overview
11.11.3 Roche Holdings Cell-Free DNA (cfDNA) Testing Introduction
11.11.4 Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.11.5 Roche Holdings Recent Development
11.12 Sequenom
11.12.1 Sequenom Company Detail
11.12.2 Sequenom Business Overview
11.12.3 Sequenom Cell-Free DNA (cfDNA) Testing Introduction
11.12.4 Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.12.5 Sequenom Recent Development
11.13 Trovagene
11.13.1 Trovagene Company Detail
11.13.2 Trovagene Business Overview
11.13.3 Trovagene Cell-Free DNA (cfDNA) Testing Introduction
11.13.4 Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
11.13.5 Trovagene Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables

List of Tables
Table 1. Global Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Donor-Derived Cell-Free DNA (DdcfDNA)
Table 3. Key Players of Circulating Cell-Free Tumor DNA (CtDNA)
Table 4. Key Players of Cell-Free Fetal DNA (NIPT)
Table 5. Global Cell-Free DNA (cfDNA) Testing Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Cell-Free DNA (cfDNA) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Cell-Free DNA (cfDNA) Testing Market Share by Region (2019-2024)
Table 9. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Cell-Free DNA (cfDNA) Testing Market Share by Region (2025-2030)
Table 11. Cell-Free DNA (cfDNA) Testing Market Trends
Table 12. Cell-Free DNA (cfDNA) Testing Market Drivers
Table 13. Cell-Free DNA (cfDNA) Testing Market Challenges
Table 14. Cell-Free DNA (cfDNA) Testing Market Restraints
Table 15. Global Cell-Free DNA (cfDNA) Testing Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Cell-Free DNA (cfDNA) Testing Market Share by Players (2019-2024)
Table 17. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2023)
Table 18. Ranking of Global Top Cell-Free DNA (cfDNA) Testing Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Cell-Free DNA (cfDNA) Testing Product Solution and Service
Table 22. Date of Enter into Cell-Free DNA (cfDNA) Testing Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Cell-Free DNA (cfDNA) Testing Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2019-2024)
Table 26. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Type (2025-2030)
Table 28. Global Cell-Free DNA (cfDNA) Testing Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2019-2024)
Table 30. Global Cell-Free DNA (cfDNA) Testing Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Cell-Free DNA (cfDNA) Testing Revenue Market Share by Application (2025-2030)
Table 32. North America Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Cell-Free DNA (cfDNA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Cell-Free DNA (cfDNA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Cell-Free DNA (cfDNA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size by Country (2025-2030) & (US$ Million)
Table 47. Agilent Technology Company Detail
Table 48. Agilent Technology Business Overview
Table 49. Agilent Technology Cell-Free DNA (cfDNA) Testing Product
Table 50. Agilent Technology Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 51. Agilent Technology Recent Development
Table 52. Allenex Company Detail
Table 53. Allenex Business Overview
Table 54. Allenex Cell-Free DNA (cfDNA) Testing Product
Table 55. Allenex Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 56. Allenex Recent Development
Table 57. Biocept Company Detail
Table 58. Biocept Business Overview
Table 59. Biocept Cell-Free DNA (cfDNA) Testing Product
Table 60. Biocept Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 61. Biocept Recent Development
Table 62. Biodesix Company Detail
Table 63. Biodesix Business Overview
Table 64. Biodesix Cell-Free DNA (cfDNA) Testing Product
Table 65. Biodesix Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 66. Biodesix Recent Development
Table 67. CareDx Company Detail
Table 68. CareDx Business Overview
Table 69. CareDx Cell-Free DNA (cfDNA) Testing Product
Table 70. CareDx Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 71. CareDx Recent Development
Table 72. Guardant Health Company Detail
Table 73. Guardant Health Business Overview
Table 74. Guardant Health Cell-Free DNA (cfDNA) Testing Product
Table 75. Guardant Health Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 76. Guardant Health Recent Development
Table 77. Illumania Company Detail
Table 78. Illumania Business Overview
Table 79. Illumania Cell-Free DNA (cfDNA) Testing Product
Table 80. Illumania Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 81. Illumania Recent Development
Table 82. Invited Company Detail
Table 83. Invited Business Overview
Table 84. Invited Cell-Free DNA (cfDNA) Testing Product
Table 85. Invited Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 86. Invited Recent Development
Table 87. Natera Company Detail
Table 88. Natera Business Overview
Table 89. Natera Cell-Free DNA (cfDNA) Testing Product
Table 90. Natera Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 91. Natera Recent Development
Table 92. Quest Diagnostics Company Detail
Table 93. Quest Diagnostics Business Overview
Table 94. Quest Diagnostics Cell-Free DNA (cfDNA) Testing Product
Table 95. Quest Diagnostics Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 96. Quest Diagnostics Recent Development
Table 97. Roche Holdings Company Detail
Table 98. Roche Holdings Business Overview
Table 99. Roche Holdings Cell-Free DNA (cfDNA) Testing Product
Table 100. Roche Holdings Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 101. Roche Holdings Recent Development
Table 102. Sequenom Company Detail
Table 103. Sequenom Business Overview
Table 104. Sequenom Cell-Free DNA (cfDNA) Testing Product
Table 105. Sequenom Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 106. Sequenom Recent Development
Table 107. Trovagene Company Detail
Table 108. Trovagene Business Overview
Table 109. Trovagene Cell-Free DNA (cfDNA) Testing Product
Table 110. Trovagene Revenue in Cell-Free DNA (cfDNA) Testing Business (2019-2024) & (US$ Million)
Table 111. Trovagene Recent Development
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cell-Free DNA (cfDNA) Testing Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Cell-Free DNA (cfDNA) Testing Market Share by Type: 2023 VS 2030
Figure 3. Donor-Derived Cell-Free DNA (DdcfDNA) Features
Figure 4. Circulating Cell-Free Tumor DNA (CtDNA) Features
Figure 5. Cell-Free Fetal DNA (NIPT) Features
Figure 6. Global Cell-Free DNA (cfDNA) Testing Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Cell-Free DNA (cfDNA) Testing Market Share by Application: 2023 VS 2030
Figure 8. Hospital Case Studies
Figure 9. Ambulatory Surgical Centers Case Studies
Figure 10. Cancer Research Institutes Case Studies
Figure 11. Cell-Free DNA (cfDNA) Testing Report Years Considered
Figure 12. Global Cell-Free DNA (cfDNA) Testing Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Cell-Free DNA (cfDNA) Testing Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Cell-Free DNA (cfDNA) Testing Market Share by Region: 2023 VS 2030
Figure 15. Global Cell-Free DNA (cfDNA) Testing Market Share by Players in 2023
Figure 16. Global Top Cell-Free DNA (cfDNA) Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell-Free DNA (cfDNA) Testing as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Cell-Free DNA (cfDNA) Testing Revenue in 2023
Figure 18. North America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Cell-Free DNA (cfDNA) Testing Market Share by Country (2019-2030)
Figure 20. United States Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Cell-Free DNA (cfDNA) Testing Market Share by Country (2019-2030)
Figure 24. Germany Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Cell-Free DNA (cfDNA) Testing Market Share by Region (2019-2030)
Figure 32. China Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Cell-Free DNA (cfDNA) Testing Market Share by Country (2019-2030)
Figure 40. Mexico Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Cell-Free DNA (cfDNA) Testing Market Share by Country (2019-2030)
Figure 44. Turkey Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Cell-Free DNA (cfDNA) Testing Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. Agilent Technology Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 47. Allenex Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 48. Biocept Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 49. Biodesix Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 50. CareDx Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 51. Guardant Health Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 52. Illumania Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 53. Invited Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 54. Natera Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 55. Quest Diagnostics Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 56. Roche Holdings Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 57. Sequenom Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 58. Trovagene Revenue Growth Rate in Cell-Free DNA (cfDNA) Testing Business (2019-2024)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock